Establishment Labs Holdings (ESTA) Shareholder's Equity Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.65% |
| Dec 31, 2025 | -55.65% |
| Sep 30, 2025 | -49.98% |
| Jun 30, 2025 | -49.44% |
| Mar 31, 2025 | -32.26% |
| Dec 31, 2024 | 188.64% |
| Sep 30, 2024 | 7.29% |
| Jun 30, 2024 | -17.96% |
| Mar 31, 2024 | 455.78% |
| Dec 31, 2023 | 324.74% |
| Sep 30, 2023 | 1,907.04% |
| Jun 30, 2023 | 245.83% |
| Mar 31, 2023 | -133.44% |
| Dec 31, 2022 | -116.13% |
| Sep 30, 2022 | -97.53% |
| Jun 30, 2022 | -76.95% |
| Mar 31, 2022 | -34.07% |
| Dec 31, 2021 | -32.31% |
| Sep 30, 2021 | -23.02% |
| Jun 30, 2021 | -15.85% |
| Mar 31, 2021 | -19.67% |
| Dec 31, 2020 | 89.23% |
| Sep 30, 2020 | 82.55% |
| Jun 30, 2020 | 52.06% |
| Mar 31, 2020 | 47.98% |
| Dec 31, 2019 | -42.99% |
| Sep 30, 2019 | -43.10% |
| Jun 30, 2019 | 2,168.54% |
| Mar 31, 2019 | 796.69% |
| Dec 31, 2018 | 1,486.10% |
| Sep 30, 2018 | 2,469.56% |
| Jun 30, 2018 | 110.58% |